Advancement in contemporary diagnostic and therapeutic approaches for rheumatoid arthritis

Biomedicine and Pharmacotherapy

Volumn 79, Issue , 2016, Pages 52-61

  Kumar, L Dinesh ^a   Karthik, R ^a   Gayathri, N ^a   Sivasudha, T ^a  

^a BHARATHIDASAN UNIVERSITY   (India)

Author keywords

Diagnosis; Pathophysiology; Rheumatoid arthritis; Treatment strategies

Indexed keywords

CORTICOSTEROID; DISEASE MODIFYING ANTIRHEUMATIC DRUG; MARKER; NATURAL PRODUCT; NONSTEROID ANTIINFLAMMATORY AGENT; BIOLOGICAL MARKER;

ACUPUNCTURE; ALTERNATIVE MEDICINE; ARTHRODESIS; BONE DESTRUCTION; BONE EROSION; CARTILAGE DEGENERATION; DUAL ENERGY X RAY ABSORPTIOMETRY; GENE THERAPY; HUMAN; MASSAGE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; OSTEOTOMY; PATHOGENESIS; PATHOPHYSIOLOGY; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; REVIEW; RHEUMATOID ARTHRITIS; SYNOVECTOMY; SYNOVITIS; TAI CHI; YOGA; ANIMAL; ARTHRITIS, RHEUMATOID; BIOLOGICAL MODEL; BLOOD;

ANIMALS; ARTHRITIS, RHEUMATOID; BIOMARKERS; GENETIC THERAPY; HUMANS; MODELS, BIOLOGICAL;

EID: 84963643078     PISSN: 07533322     EISSN: 19506007     Source Type: Journal    
DOI: 10.1016/j.biopha.2016.02.001     Document Type: Review

References (56)

1. Itoh Y. Metalloproteinases: potential therapeutic targets for rheumatoid arthritis. Endocr. Metab. Immune Disord. Drug Targets 2015, 15:216-222.
2. Martin G.V., Kanaan S.B., Azzouz D.F., Balandraud N., Picard C., Auger I., Arnoux F., Martin M., Roudier J., Lambert N.C. A6.40Copy number increase of TLR7 and TLR8 genes in men with rheumatoid arthritis. Ann. Rheum. Dis. 2015, 74:A72.
3. Swales C., Athanasou N.A., Knowles H.J. Angiopoietin-like 4 is over-expressed in rheumatoid arthritis: a potential role in pathological bone resorption. Ann. Rheum. Dis. 2014, 73:1-8.
4. Gertel S., Amita H. Putative approaches to bypass the citrulline-specific autoimmune response in rheumatoid arthritis. Isr. Med. Assoc. J. 2014, 16:587-590.
5. Prodinger B., Ndosi M., Nordenskiöld U., Stamm T., Persson G., Andreasson I., Lundgren-Nilsson A. Rehabilitation provided to patients with rheumatoid arthritis: a comparison of three different rheumatology clinics in Austria, Sweden and the UK from the perspectives of patients and health professionals. J. Rehabil. Med. 2015, 47:174-182.
6. Sun E., Negi A., Davies R. An audit of current clinical practice in the Rheumatology Department of University Hospital Wales against the top ten quality standards for rheumatoid arthritis as defined by the British Society for rheumatology. Rheumatology 2015, 54:103.
7. Paulissen S.M., Van Hamburg J.P., Dankers W., Lubberts E. The role and modulation of CCR6+ Th17 cell populations in rheumatoid arthritis. Cytokine 2015, 74:43-53.
8. Hadjigogos K. The role of free radicals in the pathogenesis of rheumatoid arthritis. Panminerva Med. 2003, 45:7-13.
9. Pitt A.R., Spickett C.M. Mass spectrometric analysis of HOCl- and free-radical-induced damage to lipids and proteins. Biochem. Soc. Trans. 2008, 36:1077-1082.
10. McInnes L.B., Schett G. Mechanism of disease-the pathogenesis of Rheumatoid arthritis. N. Engl. J. Med. 2011, 365:2205-2219.
11. Gravallese E.M., Manning C., Tsay A., Naito A., Pan C., Amento E., Goldring S.R. Synovial tissue in rheumatoid arthritis is a source of osteoclast differentiation factor. Arthritis Rheum. 2000, 43:250-258.
12. Boyce B.F., Xing L. Biology of RANK RANKL, and osteoprotegerin. Arthritis Res. Ther. 2007, 9:1-7.
13. Nagase H., Murphy G. Metalloprotienases in cartilage matrix breakdown: the roles in rheumatoid arthritis and osteoarthritis. Proteases: Struct. Funct. 2013, 1:433-469.
14. Fotopoulos V.C., Tzinia A., Tzurbakis M., Kalfakakou V., Levidiotou-Stefanou S., Georgoulis A. Expression levels of matrix metalloproteinase (MMP)-9 and its specific inhibitor TIMP-1, in septic and aseptic arthritis of the knee. Knee Surg. Sport Traumatol. Arthrosc. 2012, 20:1159-1167.
15. Ahrens D., Koch A.E., Pope R.M., Stein-Picarella M., Niedbala M.J. Expression of matrix metalloproteinase 9 (96-kd gelatinase B) in human rheumatoid arthritis. Arthritis Rheum. 1996, 39:1576-1587.
16. Choy E. Understanding the dynamics: pathways involved in the pathogenesis of rheumatoid arthritis. Rheumatology 2012, 51:v3-v11.
17. Alghuweri A., Marafi A., Alhiary M. Use of serological markers for evaluation patients with rheumatoid arthritis. Int. J. Biol. Med. Res. 2012, 3:1397-1398.
18. Kashyap B., Tiwari U., Garg A., Kaur I.R. Diagnostic utility of anti-CCP antibodies and rheumatoid factor as inflammatory biomarkers in comparison with C-reactive protein and TNF-α in rheumatoid arthritis. Trop. J. Med. Res. 2015, 18.
19. Verma U.N., Misra R., Singh R.R., Agarwal S.S., Naik S. Serological correlates of inflammation in rheumatoid arthritis: usefulness of acute phase reactants in monitoring disease activity. J. Ind. Rheumatol. Assoc. 2002, 10:1-4.
20. Rosa Neto N.S., De Carvalho J.F., Shoenfeld Y. Screening tests for inflammatory activity: applications in rheumatology. Mod. Rheumatol. 2009, 19:469-477.
21. Colebatch A.N., Edwards C.J., Østergaard M., van der Heijde D., Balint P.V., D'Agostino M.A., Forslind K., Grassi W., Haavardsholm E.A., Haugeberg G., Jurik A.G., Landewé R.B.M., Naredo E., O'Connor P.J., Ostendorf B., Potočki K., Schmidt W.A., Smolen J.S., Sokolovic S., Watt I., Conaghan P.G. EULAR recommendations for the use of imaging of the joints in the clinical management of rheumatoid arthritis. Ann. Rheum. Dis. 2013, 72:804-814.
22. Rezaei1 H., Saevarsdottir S., Geborek P., Petersson I.F., van Vollenhoven R.F., Forslind K. Evaluation of hand bone loss by digital X-ray radiogrammetry as a complement to clinical and radiographic assessment in early rheumatoid arthritis: results from the SWEFOT trial. BMC Musculoskeletal Disorders 2013, 14:1-9.
23. Deodhar A. Dual energy X-ray absorptiometry in rheumatoid arthritis. Atlas Rheum. Arthritis. 2015, 1:157-173.
24. Patil K.R., Patil C.R., Jadhav R.B., Mahajan V.K., Patil P.R., Gaikwad P.S. Anti-arthritic activity of bartogenic acid isolated from fruits of Barringtonia racemosa Roxb. (Lecythidaceae). Evid. Based Complement. Alternat. Med. 2011, 1-7.
25. Karnati M., Chandra R.H., Veeresham C., Kishan B. Anti-arthritic activity of root bark of Oroxylum indicum (L.) vent against adjuvant-induced arthritis. Pharmacogn. Res. 2013, 5:121-128.
26. Wakefield R.J., Balint P.V., Szkudlarek M., Filippucci E., Backhaus M., D'agostino M.A., Sanchez E.N., Iagnocco A., Schmidt W.A., Bruyn G., Kane D., O'connor P.J., Manger B., Joshua F., Koski J., Grassi W., Lassere M.N.D., Swen N., Kainberger F., Klauser A., Ostergaard M., Brown A.K., Machold K.P., Conaghan P.G. Musculoskeletal ultrasound including definitions for ultrasonographic pathology. J. Rheumatol. 2005, 32:2485-2487.
27. Suter L.G., Fraenkel L., Braithwaite R.S. Role of magnetic resonance imaging in the diagnosis and prognosis of rheumatoid arthritis. Arthritis Care Res. 2011, 63:675-688.
28. McQueen F.M., Benton N., Crabbe J., Robinson E., Yeoman S., McLean L., Stewart N. What is the fate of erosions in early rheumatoid arthritis? Tracking individual lesions using X rays and magnetic resonance imaging over the first two years of disease. Ann. Rheum. Dis. 2001, 60:859-868.
29. Kim J.Y., Cho S.K., Han M., Choi Y.Y., Bae S.C., Sung Y.K. The role of bone scintigraphy in the diagnosis of rheumatoid arthritis according to the 2010 ACR/EULAR classification criteria. J. Korean Med. Sci. 2014, 29:204-209.
30. Gotthardt M., Bleeker-Rovers C.P., Boerman O.C., Oyen W.J.G. Imaging of inflammation by PET conventional scintigraphy, and other imaging techniques. J. Nucl. Med. 2010, 51:1937-1949.
31. Schoellnast H., Deutschmann H.A., Hermann J., Schaffler G.J., Reittner P., Huber F.K., Szolar D.H., Preidler K.W. Psoriatic arthritis and rheumatoid arthritis: findings in contrast-enhanced MRI. AJR Am. J. Roentgenol. 2006, 187:351-357.
32. Blakstein A. Ultrasound in the diagnosis of clinical orthopaedics: The orthopaedic stethoscope. World J. Orthop. 2011, 2:13-24.
33. Stańczyk J., Kowalski M.L. The role of cyclooxygenase and prostaglandins in the pathogenesis of rheumatoid arthritis. Pol. Merkur. Lekarski. 2001, 11:438-443.
34. Cutolo M., Spies C.M., Buttgereit F., Paolino S., Pizzorni C. The supplementary therapeutic DMARD role of low-dose glucocorticoids in rheumatoid arthritis. Arthritis Res. Ther. 2014, 16:1-6.
35. Peres R.S., Liew F.Y., Talbot J., Carregaro V., Oliveira R.D., Almeida S.L., Franca R.F., Donate P.B., Pinto L.G., Ferreira F.I., Costa D.L., Demarque D.P., Gouvea D.R., Lopes N.P., Queiroz R.H., Silva J.S., Figueiredo F., Alves-Filho J.C., Cunha T.M., Ferreira S.H., Louzada-Junior P., Cunha F.Q. Low expression of CD39 on regulatory T cells as a biomarker for resistance to methotrexate therapy in rheumatoid arthritis. Proc. Natl. Acad. Sci. 2015, 112:2509-2514.
36. Zahidah A.F., Faizah O., Aqilah K.N., Anna K.T. Curcumin as an anti-arthritic agent in collagen-induced arthritic Sprague-Dawley rats. Sains Malaysiana 2012, 41:591-595.
37. Elmali N., Baysal O., Harma A., Esenkaya I., Mizrak B. Effects of resveratrol in inflammatory arthritis. Inflammation 2007, 30:1-6.
38. Jeyadevi R., Sivasudha T., Rameshkumar A., Ananth D.A., Aseervatham G.S., Kumaresan K., Kumar L.D., Jagadeeswari S., Renganathan R. Enhancement of anti arthritic effect of quercetin using thioglycolic acid-capped cadmium telluride quantum dots as nanocarrier in adjuvant induced arthritic Wistar rats. Colloids Surf. B Biointerfaces. 2013, 112:255-263.
39. Tang L.I., Wei W., Wang X.Y. Effects and mechanisms of catechin for adjuvant arthritis in rats. Adv. Ther. 2007, 24:679-690.
40. Wang H.Z., Wang H.H., Huang S.S., Zhao H., Cao Y.G., Wang G.Z., Wang D., Wang Z.G., Liu Y.H. Inhibitory effect of baicalin on collagen-induced arthritis in rats through the nuclear factor-kB pathway. J. Pharmacol. Exp. Ther. 2014, 350:435-443.
41. Zhang W., Lu C., Liu Z., Yang D., Chen S., Cha A., Wu Z., Lu A. Therapeutic effect of combined triptolide and glycyrrhizin treatment on rats with collagen induced arthritis. Planta Med. 2007, 73:336-340.
42. Luczkiewicz P., Kokotkiewicz A., Dampc A., Luczkiewicz M. Mangiferin: a promising therapeutic agent for rheumatoid arthritis treatment. Med. Hypotheses 2014, 83:570-574.
43. Lee L.T., Tsai Y.F., Hu N.Y., Wang C.W., Huang K.K., Hsiao J.K., Shih Y.C., Munekazu I. Anti-arthritis effect of mangostins from G. Mangostana. Biomed. Prev. Nutr. 2013, 3:227-232.
44. Pillai N.R., Santhakumari G. Anti-arthritic and anti-inflammatory actions of nimbidin. Planta Med. 1981, 43:59-63.
45. You X., Pan M., Gao W., Shiah H.S., Tao J., Zhang D., Koumpouras F., Wang S., Zhao H., Madri J.A., Baker D., Cheng Y.C., Yin Z. Effects of a novel tylophorine analog on collagen-induced arthritis through inhibition of the innate immune response. Arthritis Rheum. 2006, 54:877-886.
46. Woods J.M., Sitabkhan Y., Koch A.E. Gene therapy for rheumatoid arthritis: recent advances. Curr. Gene Ther. 2008, 8:24-41.
47. Thiolat A., Denys A., Petit M., Biton J., Lemiter D., Herve R., Lutomski D., Boissier M.C., Bessis N. Interleukin-35 gene therapy exacerbates experimental rheumatoid arthritis in mice. Cytokine. 2014, 69:87-93.
48. Imboden J.B. The immunopathogenesis of rheumatoid arthritis. Annu. Rev. Pathol. 2009, 4:417-434.
49. Trieb K., Hofstaetter S.G., Panotopoulos J., Wanivenhaus A. The Weil osteotomy for correction of the severe rheumatoid forefoot. Int. Orthop. 2013, 37:1795-1798.
50. Kanbe K., Chiba J., Inoue Y., Taguchi M., Iwamatsu A. Analysis of clinical factors related to the efficacy of shoulder arthroscopic synovectomy plus capsular release in patients with rheumatoid arthritis. Eur. J. Orthop. Surg. Traumatol. 2015, 25:451-455.
51. Ibrahim M.S., Jordan R.W., Kallala R., Koris J., Chakrabarti I. Total proximal interphalangeal joint arthroplasty for osteoarthritis versus rheumatoid arthritis-a systematic review. Hand Surg. 2015, 20:181-190.
52. Schuh R., Hofstaetter J., Krismer M., Bevoni R., Windhager R., Trnka H.J. Total ankle arthroplasty versus ankle arthrodesis, comparison of sports, recreational activities and functional outcome. Int. Orthop. 2012, 36:1207-1214.
53. Nair R., Kachroo S., Chawla R., Thakur G. Improvement in physical parameters of rheumatoid arthritis patients by naturopathy and yoga. Int. J. Multidiscip. Approach Stud. 2014, 3:1906-1910.
54. Telles S., Naveen K.V., Gaur V., Balkrishna A. Effect of one week of yoga on function and severity in rheumatoid arthritis. BMC Res. Notes 2011, 4:1-4.
55. Han A., Judd M., Welch V., Wu T., Tugwell P., Wells G.A. Tai chi for treating rheumatoid arthritis. Cochrane Database of Syst. Rev. 2004, 3:1-15.
56. Lee J.A., Son M.J., Choi J., Yun K.J., Jun J.H., Lee M.S. Bee venom acupuncture for rheumatoid arthritis: a systematic review protocol. BMJ Open. 2014, 4:1-4.